Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.

Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.

<h4>Background</h4>Increased mortality among men on antiretroviral therapy (ART) has been documented but remains poorly understood. We examined the magnitude of and risk factors for gender differences in mortality on ART.<h4>Methods and findings</h4>Analyses included 46,201 A...

Full description

Bibliographic Details
Main Authors:	Morna Cornell, Michael Schomaker, Daniela Belen Garone, Janet Giddy, Christopher J Hoffmann, Richard Lessells, Mhairi Maskew, Hans Prozesky, Robin Wood, Leigh F Johnson, Matthias Egger, Andrew Boulle, Landon Myer, International Epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS Medicine
Online Access:	https://doi.org/10.1371/journal.pmed.1001304

Similar Items

Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies.
by: Leigh F Johnson, et al.
Published: (2013-01-01)

Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared.
by: Olivia Keiser, et al.
Published: (2008-07-01)

Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission.
by: Patience Nyakato, et al.
Published: (2020-01-01)

Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study.
by: Leigh F Johnson, et al.
Published: (2017-12-01)

Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality.
by: Martin W G Brinkhof, et al.
Published: (2009-04-01)

Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling study.
by: Janne Estill, et al.
Published: (2013-01-01)

Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region.
by: Stephen Wright, et al.
Published: (2013-01-01)

Drivers of sex differences in the South African adult tuberculosis incidence and mortality trends, 1990–2019
by: Mmamapudi Kubjane, et al.
Published: (2023-06-01)

How should access to antiretroviral treatment be measured?
by: Leigh F Johnson, et al.

How should access to antiretroviral treatment be measured?
by: Leigh F Johnson, et al.
Published: (2011-02-01)

Pregnancy and virologic response to antiretroviral therapy in South Africa.
by: Daniel Westreich, et al.
Published: (2011-01-01)

The importance of clinic attendance in the first six months on antiretroviral treatment: a retrospective analysis at a large public sector HIV clinic in South Africa
by: Alana T Brennan, et al.
Published: (2010-01-01)

Incident pregnancy and time to death or AIDS among HIV-positive women receiving antiretroviral therapy.
by: Daniel Westreich, et al.
Published: (2013-01-01)

Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening.
by: Lukas Fenner, et al.
Published: (2013-01-01)

Prior exposure to antiretroviral therapy among adult patients presenting for HIV treatment initiation or reinitiation in sub-Saharan Africa: a systematic review
by: David B Flynn, et al.
Published: (2023-11-01)

Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries
by: Martin WG Brinkhof, et al.
Published: (2008-07-01)

Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program.
by: Kate Clouse, et al.
Published: (2017-01-01)

Delivery of antiretroviral therapy to HIV-infected women during the postpartum period: The Postpartum Adherence Clubs for Antiretroviral Therapy (PACART) trial
by: Jasantha Odayar, et al.
Published: (2019-12-01)

Integration of antiretroviral therapy services into antenatal care increases treatment initiation during pregnancy: a cohort study.
by: Kathryn Stinson, et al.
Published: (2013-01-01)

Linkage of HIV-infected infants from diagnosis to antiretroviral therapy services across the Western Cape, South Africa.
by: Nei-Yuan Hsiao, et al.
Published: (2013-01-01)

Duration of anti-tuberculosis therapy and timing of antiretroviral therapy initiation: association with mortality in HIV-related tuberculosis.
by: Claudia P Cortes, et al.
Published: (2013-01-01)

Gender inequality: Bad for men's health
by: Morna Cornell
Published: (2013-02-01)

High rate of virological re-suppression among patients failing second-line antiretroviral therapy following enhanced adherence support: A model of care in Khayelitsha, South Africa
by: D B Garone, et al.
Published: (2013-11-01)

Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies.
by: Andrew Boulle, et al.
Published: (2014-09-01)

Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study.
by: Samantha R Kaplan, et al.
Published: (2017-11-01)

Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009.
by: David B Hanna, et al.
Published: (2013-01-01)

Systemic delays in the initiation of antiretroviral therapy during pregnancy do not improve outcomes of HIV-positive mothers: a cohort study
by: Myer Landon, et al.
Published: (2012-09-01)

Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
by: Sydney Rosen, et al.
Published: (2016-05-01)

Correction: Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
by: Sydney Rosen, et al.
Published: (2016-06-01)

Combined antiretroviral and antituberculosis drug resistance following incarceration
by: Katharine Elizabeth Stott, et al.
Published: (2013-09-01)

Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa
by: Maskew Mhairi, et al.
Published: (2011-11-01)

Physical development and mental health in South African perinatally HIV-positive adolescents on antiretroviral therapy and their caregivers with and without household food insecurity
by: Sarah Heany, et al.
Published: (2021-12-01)

Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care.
by: Mhairi Maskew, et al.
Published: (2018-01-01)

Guidelines for antiretroviral therapy in adults
by: G Meintjes, et al.
Published: (2012-08-01)

Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa
by: Bangani Nonzwakazi, et al.
Published: (2007-05-01)

Assessment of facility-level antiretroviral treatment patient status utilizing a national-level laboratory cohort: Toward an understanding of system-level tracking and clinic switching in South Africa
by: Joshua P. Murphy, et al.
Published: (2022-12-01)

Record linkage augments cancer ascertainment in HIV cohorts in South Africa
by: Mazvita Sengayi, et al.
Published: (2017-04-01)

Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE.
by: CASCADE (Concerted Action on SeroConversion to AIDS and Death in Europe) Collaboration
Published: (2000)

Complications of antiretroviral therapy initiation in hospitalised patients with HIV-associated tuberculosis.
by: Helen van der Plas, et al.
Published: (2013-01-01)

Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa.
by: Matthias Egger, et al.
Published: (2011-01-01)